Received Nov 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | UNK | — | — |
Received HEPLISAV-B, Positive Test Result for Hepatitis B; Initial report received on 04-Nov-2025. A pharmacist reported that a female patient received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization then showed a positive test result for hepatitis B virus. No medical history or concomitant medications were reported. On 24-Oct-2025, the patient received an unknown dose of a hepatitis B vaccine [HEPLISAV-B (lot number, expiration date, NDC number, route, and site not available)]. On 28-Oct-2025, four days after receiving HEPLISAV-B, the patient attempted to donate blood but was denied donation because she showed a positive test result for hepatitis B virus. No additional information was reported. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.